Matthew Mikels

Array ( [id] => 864842 [patent_doc_number] => 07368430 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-06 [patent_title] => 'Selective inhibitors of nuclear factor-κB activation and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/981082 [patent_app_country] => US [patent_app_date] => 2004-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 20 [patent_no_of_words] => 6518 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/368/07368430.pdf [firstpage_image] =>[orig_patent_app_number] => 10981082 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5638036 [patent_doc_number] => 20060069010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Detoxification depot for Alzheimer\'s disease' [patent_app_type] => utility [patent_app_number] => 10/966919 [patent_app_country] => US [patent_app_date] => 2004-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4947 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20060069010.pdf [firstpage_image] =>[orig_patent_app_number] => 10966919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 121699 [patent_doc_number] => 07709443 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-04 [patent_title] => 'Cyclic peptide antitumor agents' [patent_app_type] => utility [patent_app_number] => 10/962168 [patent_app_country] => US [patent_app_date] => 2004-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 12172 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/709/07709443.pdf [firstpage_image] =>[orig_patent_app_number] => 10962168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8017301 [patent_doc_number] => 08138153 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-20 [patent_title] => 'Potassium channel modulator peptide' [patent_app_type] => utility [patent_app_number] => 10/589959 [patent_app_country] => US [patent_app_date] => 2004-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3435 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/138/08138153.pdf [firstpage_image] =>[orig_patent_app_number] => 10589959 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5721455 [patent_doc_number] => 20060074231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Amino acid-containing compounds and derivatives labeled with halides and method of making' [patent_app_type] => utility [patent_app_number] => 10/957220 [patent_app_country] => US [patent_app_date] => 2004-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4423 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20060074231.pdf [firstpage_image] =>[orig_patent_app_number] => 10957220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6906368 [patent_doc_number] => 20050101763 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Synthesis of photolabile 2-(2-nitrophenyl)propyloxycarbonyl protected amino acids' [patent_app_type] => utility [patent_app_number] => 10/954430 [patent_app_country] => US [patent_app_date] => 2004-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5283 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20050101763.pdf [firstpage_image] =>[orig_patent_app_number] => 10954430 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7098424 [patent_doc_number] => 20050130883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Serine protease inhibitors' [patent_app_type] => utility [patent_app_number] => 10/957266 [patent_app_country] => US [patent_app_date] => 2004-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9453 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20050130883.pdf [firstpage_image] =>[orig_patent_app_number] => 10957266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 239702 [patent_doc_number] => 07592419 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-22 [patent_title] => 'Macrocyclic inhibitors of hepatitis C virus NS3-serine protease' [patent_app_type] => utility [patent_app_number] => 10/948367 [patent_app_country] => US [patent_app_date] => 2004-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53340 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/592/07592419.pdf [firstpage_image] =>[orig_patent_app_number] => 10948367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5793986 [patent_doc_number] => 20060014667 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Peptide composition and method for delivering substances into the cytosol of cells' [patent_app_type] => utility [patent_app_number] => 10/945153 [patent_app_country] => US [patent_app_date] => 2004-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 14037 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20060014667.pdf [firstpage_image] =>[orig_patent_app_number] => 10945153 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7145312 [patent_doc_number] => 20050119189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Inhibitors of serine proteases, particularly HCV NS3-NS4A protease' [patent_app_type] => utility [patent_app_number] => 10/943265 [patent_app_country] => US [patent_app_date] => 2004-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22849 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20050119189.pdf [firstpage_image] =>[orig_patent_app_number] => 10943265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7011372 [patent_doc_number] => 20050065088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and parathyroid hormone' [patent_app_type] => utility [patent_app_number] => 10/946585 [patent_app_country] => US [patent_app_date] => 2004-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14133 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20050065088.pdf [firstpage_image] =>[orig_patent_app_number] => 10946585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5154360 [patent_doc_number] => 20070037243 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Process for producing alpha-glycosylated dipeptide and method of assaying alpha-glycosylated dipeptide' [patent_app_type] => utility [patent_app_number] => 10/572052 [patent_app_country] => US [patent_app_date] => 2004-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9211 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20070037243.pdf [firstpage_image] =>[orig_patent_app_number] => 10572052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6991411 [patent_doc_number] => 20050090448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Peptides that inhibit complement activation' [patent_app_type] => utility [patent_app_number] => 10/937912 [patent_app_country] => US [patent_app_date] => 2004-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 18692 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20050090448.pdf [firstpage_image] =>[orig_patent_app_number] => 10937912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6991410 [patent_doc_number] => 20050090447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Peptides that promote complement activation' [patent_app_type] => utility [patent_app_number] => 10/938088 [patent_app_country] => US [patent_app_date] => 2004-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11708 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20050090447.pdf [firstpage_image] =>[orig_patent_app_number] => 10938088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14089 [patent_doc_number] => 07807844 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-05 [patent_title] => 'TGF-β gene expression inhibitor' [patent_app_type] => utility [patent_app_number] => 10/570159 [patent_app_country] => US [patent_app_date] => 2004-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 9 [patent_no_of_words] => 8622 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/807/07807844.pdf [firstpage_image] =>[orig_patent_app_number] => 10570159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7011370 [patent_doc_number] => 20050065086 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Use of peptide-drug conjugation to reduce inter-subject variability of drug serum levels' [patent_app_type] => utility [patent_app_number] => 10/923089 [patent_app_country] => US [patent_app_date] => 2004-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8808 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20050065086.pdf [firstpage_image] =>[orig_patent_app_number] => 10923089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5591402 [patent_doc_number] => 20060040854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => 'Prostate hyperplasia therapy' [patent_app_type] => utility [patent_app_number] => 10/920886 [patent_app_country] => US [patent_app_date] => 2004-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6288 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20060040854.pdf [firstpage_image] =>[orig_patent_app_number] => 10920886 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7061671 [patent_doc_number] => 20050004033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Use of isolated domains of type IV collagen to modify cell and tissue interaction' [patent_app_type] => utility [patent_app_number] => 10/903827 [patent_app_country] => US [patent_app_date] => 2004-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 5557 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20050004033.pdf [firstpage_image] =>[orig_patent_app_number] => 10903827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7353680 [patent_doc_number] => 20040249187 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Method for producing chiral amino acid derivatives' [patent_app_type] => new [patent_app_number] => 10/481499 [patent_app_country] => US [patent_app_date] => 2004-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4012 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20040249187.pdf [firstpage_image] =>[orig_patent_app_number] => 10481499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 377091 [patent_doc_number] => 07312191 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-12-25 [patent_title] => 'Conjugated nitro alkene anticancer agents based on isoprenoid metabolism' [patent_app_type] => utility [patent_app_number] => 10/901082 [patent_app_country] => US [patent_app_date] => 2004-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11315 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/312/07312191.pdf [firstpage_image] =>[orig_patent_app_number] => 10901082 [rel_patent_id] =>[rel_patent_doc_number] =>)